| |
|
|
Recommendations - Pertussis |
|
|
|
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee
on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5 |
|
|
HTML | PDF |
|
|
| |
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70 |
|
|
HTML | PDF |
|
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
Vaccine (Tdap) in Pregnant Women and Persons Who Have or
Anticipate Having Close Contact with an Infant Aged <12 Months --
Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426 |
|
|
HTML | PDF |
| |
Updated Recommendations for Use of
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis
(Tdap) Vaccine from the Advisory Committee on Immunization
Practices, 2010
Source: MMWR, January 14, 2011;
60(01):13-15 |
|
|
HTML | PDF |
| |
Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their Infants:
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57
(04):1-47,51 |
|
|
HTML pt 1 |
HTML pt 2 |
HTML pt 3 |
PDF |
| |
Preventing Tetanus,
Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced
Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this
document, be sure to access all four HTML links to get the complete content
of the document,
which includes 3 important appendices.
Source: MMWR, December
15, 2006;55(RR-17):1-33 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | PDF
(entire issue) |
| |
Use of Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among
Adolescents
Please note: If you are using the HTML version of this document, be sure
to access all the HTML links to get the complete content of the document,
which includes important appendices.
Source:
MMWR, March 24, 2006, Vol. 55(RR03):1-49 |
|
| HTML
pt.1 | HTML
pt.2 | HTML
pt.3 | HTML
pt.4 | HTML
pt.5 | HTML
pt.6 | HTML
pt.7 | PDF
(entire issue) |
| |
CDC
Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment
and Postexposure Prophylaxis of Pertussis
(not an ACIP statement but a recommendation from NIP, CDC)
Source: MMWR, December 9, 2005, Vol. 54(RR14):1-16 |
|
| HTML | PDF |
| |
Use of Diphtheria
Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose
Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13 |
|
| HTML | PDF |
| |
Use of Acellular
Pertussis Vaccines
Source: MMWR March 28, 1997 / Vol. 46 / No. RR-7 |
|
| HTML | PDF |
| |
Diphtheria,
Tetanus, and Pertussis, Recommendations for Vaccine Use and Other
Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10 |
|
| HTML | PDF |
|
| This page was reviewed
on February 21, 2013 |
A-Z
IAC Home